By Ernie Mundell HealthDay ReporterTHURSDAY, July 31, 2025 (HealthDay News) — There’s potentially exciting news from a trial ...

Plasma samples showed an association between suppressed extracellular vesicles and an increased risk for liver cancer.

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

The Trump administration is appealing the court order to reinstate grants and says it will fight “divisive DEI” in science.

The launch, supported by the International Labour Organization (ILO), was held at Government Complex in Lusaka and brought ...

A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...

AAV gene therapy in early life provides lasting HIV protection in primates—offering hope for pediatric HIV intervention in ...

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...